Oncology Business Management | Specialty

Choosing Therapy for Newly Diagnosed NonDriver NSCLC

February 26th 2019

Driver Mutations Trump PD-L1 Expression in Lung Adenocarcinoma

February 26th 2019

Biomarker Testing in Stage III NSCLC

February 26th 2019

Imaging Schedule Following CRT in Locally Advanced NSCLC

February 26th 2019

The Role of Surgery in NSCLC Following PACIFIC Trial

February 26th 2019

Impact of PACIFIC Trial on Locally Advanced NSCLC

February 26th 2019

CMS' Healthcare Reform Efforts Make Waves

February 20th 2019

Under the current administration, a policy implemented at the turn of the year could have far-reaching effects on the healthcare reform effort.

Heightened Risk for Natural Disasters Necessitates Advance Preparation in Oncology Community

February 5th 2019

With hugely destructive storms now almost routine—3 of the 5 costliest hurricanes on record occurred in 2017—the secret to practice readiness is constant review and analysis.

Intellectual Conflicts of Interest Pose Hidden Dangers to Scientific Accuracy

February 1st 2019

The model of an independent and self-regulating academic medical community continues to be challenged through widely reported accusations of serious scientific misconduct, failure of investigators to report potential financial conflicts of interest, and suggestions of inadequate transparency related to the questionable role of academic researchers in the analysis and reporting of industry-sponsored clinical trial results.

Overcoming Acquired Resistance Mechanisms in BRAF+ mCRC

January 31st 2019

First-Line Triplet in BRAF+ mCRC

January 31st 2019

Real-World Management of Patients with BRAF-V600E mCRC

January 31st 2019

CRC Safety Lead-in: ASCO GI 2019 Updates

January 31st 2019

Combining BRAF, MEK and EGFR Inhibition in mCRC

January 31st 2019

Lack of Durable Responses in Current Treatment of mCRC

January 31st 2019

Sequencing Strategies in BRAF-Mutated mCRC

January 31st 2019

Prognosticating BRAF-Mutant mCRC

January 31st 2019

Expert Discusses How Data Informatics Is Driving Drug Development

January 29th 2019

Subha Madhavan, PhD, discusses the role of data science and informatics in bringing novel clinical study designs to the field of oncology.

Blood Cancers Associated With Higher Treatment and Out-of-Pocket Costs

January 25th 2019

Patients with blood cancers face greater treatment costs than those with solid tumors. Furthermore, healthcare spending for these patients is already higher than average before diagnosis and does not return to prediagnosis levels even after successful treatment.

Be More Sensitive to the Toxicities of Cancer Therapy

January 16th 2019

The concept of chronic disease management in cancer has been and continues to be inadequately considered.